Exploratory Analysis of Neuroimaging and Molecular Findings in a Cohort of Neuronal Ceroid Lipofuscinosis: a Descriptive study
Journal of Molecular Neuroscience · 12.06.2026 · 76 (2)
DOI: 10.1007/s12031-026-02553-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Neuroscience, online erschienen am 12.06.2026. Verfasst von Elham Rahimian und 12 weiteren Autor:innen. Beteiligte Einrichtung: Haghighat Medical Imaging Center, E Janbazan St, PFJW+269, Tehran, Iran. Hauptthemen laut MEDLINE: Neuronal Ceroid-Lipofuscinoses, Brain. Die Arbeit nennt 39 Literaturangaben.
Abstract (Originalsprache)
Neuronal ceroid lipofuscinosis (NCL) is a group of progressive neurodegenerative disorders affecting the brain and retina. This study descriptively characterizes Magnetic Resonance Imaging (MRI) and Proton Magnetic Resonance Spectroscopy (^1H MRS) features across NCL subtypes in 16 patients and preliminarily explores potential associations with clinical severity and genetic findings. Due to the small sample size, no definitive genotype-phenotype correlations could be established; rather, we report observed imaging patterns as hypothesis-generating observations. MRI demonstrated patterns such as thalamic T2-weighted hypointensity and periventricular white matter signal abnormalities, which may reflect disease burden and progression. ^1H MRS, performed in a subset of patients, showed reduced N-Acetyl Aspartate and variable choline peaks. Notably, preliminary subtype-specific metabolic trends were observed across the four subtypes in which MRS was performed, suggesting the potential for metabolite profiling to aid in diagnosis and subtype differentiation. However, these findings are merely exploratory and require validation in larger cohorts. These preliminary findings suggest a complementary role for advanced neuroimaging alongside molecular testing in the early diagnosis and evaluation of NCL, though larger prospective studies are needed to validate these observations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Haghighat Medical Imaging Center, E Janbazan St, PFJW+269, Tehran, Iran.
- Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Faculty of Psychiatry, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran.
- Division of Neurology, Barrow Neurological Institute at Phoenix Children's Hospital, Phoenix, AZ, USA.
- Myelin Disorders Clinic, Department of Pediatric Neurology, Children's Medical Center, Pediatrics Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Pediatric Neurology, Hakim Children's Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Zitieren
APA
Rahimian, E., Tahsini, M. R., Fathi, M., Khalilian, S., Farahvash, M. A., Tavasoli, A. R., Shahbodagh Khan, G., Ashrafi, M. R., Saket, S., Rahmanian, M., Miryounesi, M., Ghafouri-Fard, S., & Heidari, M. (2026). Exploratory Analysis of Neuroimaging and Molecular Findings in a Cohort of Neuronal Ceroid Lipofuscinosis: a Descriptive study. Journal of Molecular Neuroscience, 76(2). https://doi.org/10.1007/s12031-026-02553-6
Vancouver
Rahimian E, Tahsini MR, Fathi M, Khalilian S, Farahvash MA, Tavasoli AR, et al. Exploratory Analysis of Neuroimaging and Molecular Findings in a Cohort of Neuronal Ceroid Lipofuscinosis: a Descriptive study. Journal of Molecular Neuroscience. 2026;76(2). doi:10.1007/s12031-026-02553-6
BibTeX
@article{Rahimian2026,
author = {Rahimian, Elham and Tahsini, Majid R and Fathi, Mohadeseh and Khalilian, Sheyda and Farahvash, Mohammad Aidin and Tavasoli, Ali Reza and Shahbodagh Khan, Golazin and Ashrafi, Mahmoud Reza and Saket, Sasan and Rahmanian, Mohammad and Miryounesi, Mohammad and Ghafouri-Fard, Soudeh and Heidari, Morteza},
title = {Exploratory Analysis of Neuroimaging and Molecular Findings in a Cohort of Neuronal Ceroid Lipofuscinosis: a Descriptive study},
journal = {Journal of Molecular Neuroscience},
year = {2026},
volume = {76},
number = {2},
doi = {10.1007/s12031-026-02553-6}
}
EUVIMED